Cell culture market size will reach USD 56.19 billion by


Newark, Nov. 08, 2022 (GLOBE NEWSWIRE) — Cell Culture Market Size From $20.96 Billion to $56.19 Billion in 8 Years: Rising Research and Development to Harness the Potential of cell culture in medicine will propel the market growth in the coming years

Upcoming Opportunities

Brainy Insights estimates that the cell culture market from $20.96 billion in 2022 will grow to $56.19 billion by 2030. Given the climate change crisis, increasing weather volatility has increased the risk that new bacteria, viruses and other pathogens invade the ecosystem. , leading to catastrophic consequences. Accelerating climate change has increased the likelihood of re-emergence of historically endemic pathogens. New chronic diseases, acute illnesses and other conditions have increased in number despite advances in healthcare technology and improved services. Cell culture will help researchers and scientists understand the underlying causes of these diseases and conditions in order to prevent their widespread destruction and save lives. The pace of this research to understand potential future outbreaks that could cause pandemics has accelerated after the devastating two years of the covid-19 pandemic. Cell culture will form the basis of diagnosis, prognosis, and future treatment plans for most conditions and diseases. Hence, the global cell culture market will grow exponentially during the forecast period 2022-30.

Request a Sample Market Scope and Parent Market Analysis PDF: https://www.thebrainyinsights.com/enquiry/sample-request/13000

Key overview of the cell culture market

Asia-Pacific is expected to experience the fastest growth over the forecast period.

During the projected period, the Asia-Pacific market is expected to grow the fastest owing to increasing tax expenditures and government measures aimed at strengthening the regulatory environment in the region. Major market players will be attracted to the region, offering favorable growth prospects. The market will grow, given the demand for locally developed vaccines and other pharmaceutical drugs/treatments. The regional market will grow owing to the growing awareness about cell culture applications and their benefits. The well-established and constantly growing pharmaceutical and biotechnology industries have a significant impact on the growth of the market.

The consumables segment will grow the cell culture market over the forecast period.

The product type segment is divided into consumables and equipment. The consumables segment held the largest market share in 2022 and is expected to continue during the forecast period owing to the increase in expenditure for these products.

The tissue engineering and regenerative medicine segment is expected to grow the cell culture market over the forecast period.

The applications segment is divided into stem cell technology, drug screening and development, cancer research, tissue engineering and regenerative medicine, biopharmaceutical production, diagnostics and others. The tissue engineering and regenerative medicine segment held the largest market share in 2022 and is expected to continue during the forecast period owing to the wide range of applications the segment offers.

The market size of the segment of pharmaceutical and biotechnology companies of 12.15 billion in 2022

The end user segment is divided into hospitals, research institutes, pharmaceutical and biotechnology companies, etc. The pharmaceutical and biotechnology companies segment is expected to dominate the market over the forecast period owing to the increase in research and development expenditure.

Get full report summary describing market size and forecast: https://www.thebrainyinsights.com/report/cell-culture-market-13000

Cell Culture Market Scope:

Report cover Details
Page number 237
Year of reference 2021
Forecast period 2022-2030
Growth momentum and CAGR Accelerate at a CAGR of 13.12%
Market Growth 2022-2030 $56.19 billion
Market structure Fragmented
Regional analysis APAC, Europe, North America, South America and MEA
Successful market contribution The cell culture market share in the North American region in 2022 is 41.18%.
Competitive landscape Leading companies, competitive strategies, scope of consumer engagement
Profiled companies Becton, Dickinson, and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, Danaher Corporation, Eppendorf SE, Merck & Co., PromoCell GmbH, Sartorius AG, Thermo Fisher Scientific Inc.
Market dynamics Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period.
Customization overview If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Market advancement

Cytiva (Danaher Corporation) and Nucleus Biologics began working together in January 2022 to create custom culture media for cell and gene therapy. New companies are also expanding their current service offerings to increase their market position.

Market dynamics

Driver: Increase research and development to produce vaccines for future virus outbreaks

The development of the most effective vaccines is made possible by cell culture, which allows researchers to mimic real viral strains as closely as possible. The COVID-19 pandemic has brought to light the high risk of diseases, germs and viruses to come. Moreover, it has been shown that the best way to save the lives of citizens is through vaccination. Hence, the global cell culture market will be driven by the accelerated speed of research and development of vaccines to stop upcoming pandemics.

Constraint: The large capital outlay required for cell culture research and its potential applications

The growth of the global cell culture market will be hampered by the vast capital required for cell culture research followed by testing of its efficacy, production and distribution.

Opportunities: increased research and development spending

The growing research and development to manufacture effective drugs is fundamentally etched in the exploration of cell culture and its potential applications and benefits. As the number of cancer patients increases, cell culture-based oncology research is being conducted to better understand the disease and create new therapies, drugs and treatments. The demand for cell culture to advance medicine will increase due to prospective uses in stem cell therapy, genetic engineering, and engineering. Private investment spending is increasing given the prospects for profitability, innovations, and the supply of products that effectively cure or treat cancer and other chronic diseases in the future market.

Challenge: Stringent regulatory approvals

The lack of a holistic regulatory approval process leads to lengthy and duplicated procedural steps, which wastes resources. Moreover, the delay in bringing a medicine or medicine to market, given the length of the approval process, causes private players to lose windows of profitability, discouraging them from undertaking research and putting back thus in question the growth of the market.

Learn more about vendor growth strategies and product offerings: https://www.thebrainyinsights.com/enquiry/request-customization/13000

Some of the major players operating in the cell culture market are:

• Becton, Dickinson and company
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• Corning Incorporated
• Danaher Corporation
• Eppendorf SE
• Merck & Co.
• PromoCell GmbH
• Sartorius AG
• Thermo Fisher Scientific Inc.

Coverage of key segments in the market:

By product type

• Consumables
• Equipment

By app

• Stem cell technology
• Screening and drug development
• Research against cancer
• Tissue engineering and regenerative medicine
• Biopharmaceutical production
• Diagnostic
• Others

Per end user

• Hospitals
• Research institutes
• Pharmaceutical and biotechnology companies
• Others

By region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, rest of APAC)
• South America (Brazil and rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Interested in Procuring Data? Visit: https://www.thebrainyinsights.com/buy-now/13000/single

About the report:

The market is analyzed on the basis of value (USD billion). All segments have been analyzed at global, regional and country level. The study includes analysis of more than 30 countries for each part. The report analyzes the drivers, opportunities, restraints and challenges to gain a critical overview of the market. The study includes Porter’s five forces model, attractiveness analysis, product analysis, supply and demand analysis, competitor position grid analysis, analysis of distribution and marketing channels.

About The Brainy Insights:

The Brainy Insights is a market research company, aiming to provide businesses with actionable insights through data analytics to improve their business acumen. We have a robust forecasting and estimating model to meet customers’ high-quality production goals in a short period of time. We provide custom (customer specific) and syndicated reports. Our union reporting repository is diverse across all domain categories and subcategories. Our customized solutions are designed to meet customer needs, whether they are looking to expand or planning to launch a new product in the global market.

Contact us

Avinash D
Business Development Manager
Phone: +1-315-215-1633
Email: [email protected]
Web: http://www.thebrainyinsights.com


Source link

Previous Food Allergy Market: Analysis of Epidemiology, Pipeline Therapies and Key Companies Working in the Market
Next From Crispy Thai Sushi to Pumpkin Bread: Our Top Eight Vegan Recipes of the Day!